Follow
Jakub Hlávka
Jakub Hlávka
Other namesJakub P. Hlávka
Masaryk University, Brno, Czech Republic; USC Schaeffer Center, USC Keck School of Medicine
Verified email at usc.edu - Homepage
Title
Cited by
Cited by
Year
Biosimilar cost savings in the United States: initial experience and future potential
AW Mulcahy, JP Hlávka, SR Case
RAND Health Quarterly 7 (4), 2018
2412018
Artificial Intelligence in Healthcare
A Bohr, K Memarzadeh, (editors)
Academic Press, 2020
2032020
Assessing the preparedness of the US health care system infrastructure for an Alzheimer’s treatment
JL Liu, JP Hlávka, R Hillestad, S Mattke
The RAND Corporation, Santa Monica, CA, 2017
912017
Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups
National Academies of Sciences, Engineering, and Medicine
https://nap.nationalacademies.org/read/26479/chapter/1, 2022
862022
Assessing the Preparedness of the Health Care System Infrastructure in Six European Countries for an Alzheimer's Treatment
JP Hlavka, S Mattke, JL Liu
RAND Health Quarterly 8 (3), 2019
842019
Toward a Sustainable Blood Supply in the United States
AW Mulcahy, K Kapinos, B Briscombe, L Uscher-Pines, R Chaturvedi, ...
Santa Monica (CA): RAND Corporation, 2016
612016
Blood‐based biomarkers for Alzheimer's pathology and the diagnostic process for a disease‐modifying treatment: Projecting the impact on the cost and wait times
MH Soeren Mattke, Sang Kyu Cho, Tobias Bittner, Jakub Hlávka
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2020
462020
Macroeconomic consequences of the COVID-19 pandemic
T Walmsley, A Rose, R John, D Wei, JP Hlávka, J Machado, K Byrd
Economic modelling 120, 106147, 2023
302023
Assessing the preparedness of the Canadian health care system infrastructure for an Alzheimer's treatment
J Liu, J Hlávka, D Coulter, SM Baxi, S Mattke, CA Gidengil
RAND, 2019
262019
Security Sector Reform in Ukraine
O Oliker, LE Davis, K Crane, A Radin, CW Gventer, S Sondergaard, ...
RAND Corporation, 2016
232016
The potential emergence of disease-modifying treatments for Alzheimer disease: the role of primary care in managing the patient journey
J Lam, J Hlávka, S Mattke
The Journal of the American Board of Family Medicine 32 (6), 931-940, 2019
212019
US Presence and the Incidence of Conflict
A O’Mahony, BF Miranda Priebe, J Kavanagh, M Lane, T Johnston, ...
RAND Corporation, 2018
212018
Security, privacy, and information-sharing aspects of healthcare artificial intelligence
JP Hlávka
Artificial Intelligence in Healthcare, 235-270, 2020
192020
Challenges to the Sustainability of the US Public Cord Blood System
KA Kapinos, B Briscombe, T Gracner, A Strong, C Whaley, E Hoch, ...
RAND Corporation, 2017
182017
Targeted interoperability: a new imperative for multinational operations
CG Pernin, J Hlávka, ME Boyer, J Gordon, J Osburg, M Lerario, M Shurkin, ...
RAND, 2019
152019
Lessons from Others for Future US Army Operations in and Through the Information Environment
C Paul, CP Clarke, M Schwille, JP Hlávka, MA Brown, SS Davenport, ...
RAND Corporation, 2018
152018
3D printing: Downstream production transforming the supply chain
S Veronneau, G Torrington, JP Hlávka
RAND Corporation Santa Monica United States, 2017
13*2017
Assessing the preparedness of the Japanese health care system infrastructure for an Alzheimer’s treatment
S Mattke, J Hlávka, J Yoong, M Wang, R Goto
112019
The economics of alternative payment models for pharmaceuticals
JP Hlávka, JC Yu, DP Goldman, DN Lakdawalla
The European Journal of Health Economics 22, 559-569, 2021
102021
Biosimilar cost savings in the United States
AW Mulcahy, JP Hlávka, SR Case
Rand Corporation Perspective, 2017
92017
The system can't perform the operation now. Try again later.
Articles 1–20